J. Goldman & CO LP Ionis Pharmaceuticals Inc Transaction History
J. Goldman & CO LP
- $3.53 Billion
- Q4 2024
A detailed history of J. Goldman & CO LP transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, J. Goldman & CO LP holds 607,499 shares of IONS stock, worth $19.6 Million. This represents 0.6% of its overall portfolio holdings.
Number of Shares
607,499
Previous 609,416
0.31%
Holding current value
$19.6 Million
Previous $24.4 Million
13.01%
% of portfolio
0.6%
Previous 0.76%
Shares
4 transactions
Others Institutions Holding IONS
# of Institutions
412Shares Held
140MCall Options Held
829KPut Options Held
789K-
Vanguard Group Inc Valley Forge, PA16.5MShares$532 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD14.2MShares$458 Million0.31% of portfolio
-
Capital World Investors Los Angeles, CA11.5MShares$371 Million0.06% of portfolio
-
Black Rock Inc. New York, NY10.3MShares$334 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA8.67MShares$280 Million0.06% of portfolio
About IONIS PHARMACEUTICALS INC
- Ticker IONS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 141,940,992
- Market Cap $4.59B
- Description
- Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...